James W. Mccollum serves as Executive at LENZ Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, James W. Mccollum has executed 5 insider transactions totaling $740.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 7, 2025 involved purchasing 10,500 shares valued at $239.3K.
James W. Mccollum currently holds 10,500 shares of LENZ Therapeutics, Inc. (LENZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James W. Mccollum has been a net buyer of LENZ stock. They have purchased $740.3K and sold $0 worth of shares.
James W. Mccollum's most recent insider trade was on Nov 7, 2025, when they purchased 10,500 shares at $22.79 per share.
Get notified when new Form 4 filings are submitted
| $15.99 |
| Discretionary |
| Mar 21, 2024 | LENZ | $250.0K | Award | 16,633 | $15.03 | Discretionary |
| Mar 21, 2024 | LENZ | $0 | Award | 477,600 | $N/A | Discretionary |
| Mar 21, 2024 | LENZ | $0 | Award | 95,034 | $N/A | Discretionary |